Gwen O'Driscoll is a Venture Promoter at Start Codon, with previous experience as a R&D scientist at AstraZeneca. Gwen is currently a CRUK PhD Student at Imperial College London, where Gwen leads a cross-institutional project in cancer bioengineering. Gwen also has a Master's degree in Pharmacology from the University of Oxford and a Bachelor's degree in Biomedical Science from Imperial College London.
January, 2024 - present